Trade BOLD stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Boundless Bio, Inc. (BOLD) is trading at US$2.81, up 0.36% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$68.24M. Over the past 52 weeks, BOLD has traded between US$0.96 and US$3.16. On Syfe you can trade BOLD with $0 commission and add it to your watchlist.
| Previous close | US$2.80 |
|---|---|
| Market cap | US$68.24M |
| 52-week range | US$0.96 – US$3.16 |
| Volume | 346.37K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Boundless Bio, Inc.
Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F. Cravatt, and Jonathan E. Lim on April 10, 2018 and is headquartered in La Jolla, CA.
Year: 2024
Sector Update: Healthcare Stocks Higher Late Afternoon
Jun 23, 7:46 PM · MT Newswires
Sector Update: Healthcare Stocks Advance in Afternoon Trading
Jun 23, 5:38 PM · MT Newswires
Top Midday Gainers
Jun 23, 5:27 PM · MT Newswires
Sector Update: Healthcare Stocks Mixed Pre-Bell Tuesday
Jun 23, 1:14 PM · MT Newswires
Boundless Bio, Serapha Bio Sign Merger Deal With $230 Million Private Placement
Jun 23, 11:58 AM · MT Newswires
Boundless Bio, Inc. (BOLD) stock is trading at US$2.81, +0.36% from the previous close of US$2.80.
The market cap for Boundless Bio, Inc. (BOLD) stock is approximately US$68.24M.
The 52-week high for Boundless Bio, Inc. (BOLD) stock is US$3.16.
The 52-week low for Boundless Bio, Inc. (BOLD) stock is US$0.96.
Boundless Bio, Inc. (BOLD) does not currently pay a dividend.
Stay on top of BOLD
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
